IMMIX BIOPHARMA INC. - COMMON STOCK
2,2500
24-мая-24 15:57:41
15 мин. задержка
Акции
+0,1300
+6,13%
Сегодняшний диапазон
2,0500 - 2,2600
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
10 май 2024 09:35:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma
29 апр 2024 09:39:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma on Track to Dose NXC-201 Patients in United States
18 апр 2024 09:32:00 Источник Nasdaq GlobeNewswire
-
15 апр 2024 09:36:00 Источник Nasdaq GlobeNewswire
-
20 мар 2024 09:46:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Announces “Be Proactive in AL” AL Amyloidosis Awareness Initiative
05 мар 2024 09:35:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma 12 Month Review Progress Update
21 фев 2024 09:31:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Announces Closing of $15 Million Public Offering of Common Stock
08 фев 2024 16:45:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis
07 фев 2024 09:37:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock
05 фев 2024 22:30:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Announces Proposed Public Offering of Common Stock
05 фев 2024 15:20:11 Источник Nasdaq GlobeNewswire
-
24 янв 2024 08:35:00 Источник Nasdaq GlobeNewswire
-
04 янв 2024 09:34:00 Источник Nasdaq GlobeNewswire
-
18 дек 2023 09:39:00 Источник Nasdaq GlobeNewswire
-
11 дек 2023 09:36:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit
30 ноя 2023 09:46:00 Источник Nasdaq GlobeNewswire
-
22 ноя 2023 09:19:00 Источник Nasdaq GlobeNewswire
-
21 ноя 2023 09:46:00 Источник Nasdaq GlobeNewswire
-
21 ноя 2023 09:46:00 Источник Nasdaq GlobeNewswire
-
06 ноя 2023 09:12:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >